Prize Contingency Management for Cocaine-Dependent Methadone Patients
2 other identifiers
interventional
280
1 country
1
Brief Summary
The investigators will randomize 300 cocaine-dependent methadone patients to 1 of 6 conditions: (a) a control group, (b) a contingency management condition that arranges a 100% probability of winning a prize with each draw and has 3 prize categories, (c) a contingency management condition that arranges a 31% probability of winning and has 3 prize categories, (d) a contingency management condition that arranges a 100% probability of winning and has 7 prize categories, (e) a contingency management condition that arranges a 31% probability of winning and has 7 prize categories, or (f) usual prize contingency management with a 50% probability of winning from 3 prize categories. Magnitudes of reinforcement will be identical across conditions, but lower overall probability conditions arrange for greater chances of winning larger magnitude prizes. The investigators expect that the new contingency management conditions will reduce cocaine use relative to the control condition, that 31% probability conditions will decrease drug use relative to 100% conditions, and that 7-prize category conditions will reduce drug use compared to 3-prize category conditions. In addition, the 31%/7-category condition is expected to be most efficacious. Results will be instrumental for further developing prize contingency management to improve outcomes of cocaine-dependent methadone patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 22, 2011
CompletedFirst Posted
Study publicly available on registry
July 25, 2011
CompletedStudy Start
First participant enrolled
November 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2018
CompletedMarch 13, 2019
March 1, 2019
6.5 years
July 22, 2011
March 11, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
longest continuous period of cocaine abstinence
three months
Study Arms (6)
Treatment Group A
NO INTERVENTIONStandard Care
Treatment Group B
EXPERIMENTAL100% probability of winning a prize with each draw and has 3 prize categories
Treatment Group C
EXPERIMENTAL31% probability of winning and has 3 prize categories
Treatment Group D
EXPERIMENTAL100% probability of winning and has 7 prize categories
Treatment Group E
EXPERIMENTAL31% probability of winning and has 7 prize categories
Treatment Group F
EXPERIMENTALusual prize contingency management with a 50% probability of winning from 3 prize categories
Interventions
Participants earn the chance to win prizes for the targeted behavior, cocaine abstinence.
Eligibility Criteria
You may qualify if:
- age \> 18 years
- current DSM-IV diagnosis of cocaine dependence
- enrolled at the clinic for \>3 months
- on a stable dose of methadone (no changes) for \>1 month and not requesting a dose alteration
- submitted \>1 clinic cocaine positive sample in the last 6 months
- English speaking
- pass a quiz related to understanding the informed consent form
You may not qualify if:
- serious, uncontrolled psychiatric illness
- significant cognitive impairment
- in recovery from pathological gambling
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- UConn Healthlead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
University of Connecticut Health Center
Farmington, Connecticut, 06030, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sheila M Alessi, Ph.D.
UConn Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 22, 2011
First Posted
July 25, 2011
Study Start
November 1, 2011
Primary Completion
May 1, 2018
Study Completion
May 1, 2018
Last Updated
March 13, 2019
Record last verified: 2019-03